130 related articles for article (PubMed ID: 33129902)
1. Destabilisation of the structure of transthyretin is driven by Ca
Wieczorek E; Kędracka-Krok S; Bystranowska D; Ptak M; Wiak K; Wygralak Z; Jankowska U; Ożyhar A
Int J Biol Macromol; 2021 Jan; 166():409-423. PubMed ID: 33129902
[TBL] [Abstract][Full Text] [Related]
2. Deep blue autofluorescence reveals the instability of human transthyretin.
Wieczorek E; Bezara P; Ożyhar A
Int J Biol Macromol; 2021 Nov; 191():492-499. PubMed ID: 34562536
[TBL] [Abstract][Full Text] [Related]
3. Destabilised human transthyretin shapes the morphology of calcium carbonate crystals.
Wieczorek E; Chitruń A; Ożyhar A
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):313-324. PubMed ID: 30394286
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases.
Wieczorek E; Ożyhar A
Cells; 2021 Jul; 10(7):. PubMed ID: 34359938
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin microheterogeneity and molecular interactions: implications for amyloid formation.
Landreh M; Ostberg LJ; Pettersson TM; Jörnvall H
Biomol Concepts; 2014 Jun; 5(3):257-64. PubMed ID: 25372757
[TBL] [Abstract][Full Text] [Related]
6. Calcium Binds to Transthyretin with Low Affinity.
Cantarutti C; Mimmi MC; Verona G; Mandaliti W; Taylor GW; Mangione PP; Giorgetti S; Bellotti V; Corazza A
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008960
[TBL] [Abstract][Full Text] [Related]
7. Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.
Dasari AKR; Hung I; Gan Z; Lim KH
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):344-349. PubMed ID: 30366153
[TBL] [Abstract][Full Text] [Related]
8. Deep blue autofluorescence reflects the oxidation state of human transthyretin.
Wieczorek E; Wygralak Z; Kędracka-Krok S; Bezara P; Bystranowska D; Dobryszycki P; Ożyhar A
Redox Biol; 2022 Oct; 56():102434. PubMed ID: 35987087
[TBL] [Abstract][Full Text] [Related]
9. Copper mediated amyloid-β binding to Transthyretin.
Ciccone L; Fruchart-Gaillard C; Mourier G; Savko M; Nencetti S; Orlandini E; Servent D; Stura EA; Shepard W
Sci Rep; 2018 Sep; 8(1):13744. PubMed ID: 30213975
[TBL] [Abstract][Full Text] [Related]
10. Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition.
Mangrolia P; Murphy RM
Biochemistry; 2018 Aug; 57(33):5029-5040. PubMed ID: 30024734
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
[TBL] [Abstract][Full Text] [Related]
12. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.
Quintas A; Vaz DC; Cardoso I; Saraiva MJ; Brito RM
J Biol Chem; 2001 Jul; 276(29):27207-13. PubMed ID: 11306576
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway.
Dasari AKR; Arreola J; Michael B; Griffin RG; Kelly JW; Lim KH
Biochemistry; 2020 Jun; 59(25):2319-2327. PubMed ID: 32500705
[TBL] [Abstract][Full Text] [Related]
14. Mutation and low pH effect on the stability as well as unfolding kinetics of transthyretin dimer.
Xue Q; Zheng QC; Zhang JL; Cui YL; Chu WT; Zhang HX
Biophys Chem; 2014 May; 189():8-15. PubMed ID: 24632442
[TBL] [Abstract][Full Text] [Related]
15. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
Lai Z; Colón W; Kelly JW
Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
[TBL] [Abstract][Full Text] [Related]
16. Cooperative stabilization of transthyretin by clusterin and diflunisal.
Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
[TBL] [Abstract][Full Text] [Related]
17. Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Connelly S; Mortenson DE; Choi S; Wilson IA; Powers ET; Kelly JW; Johnson SM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3441-3449. PubMed ID: 28625364
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alemi M; Silva SC; Santana I; Cardoso I
CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
[TBL] [Abstract][Full Text] [Related]
19. Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers.
Yang M; Lei M; Huo S
Protein Sci; 2003 Jun; 12(6):1222-31. PubMed ID: 12761393
[TBL] [Abstract][Full Text] [Related]
20. Conformational flexibility tunes the propensity of transthyretin to form fibrils through non-native intermediate states.
Das JK; Mall SS; Bej A; Mukherjee S
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12781-4. PubMed ID: 25251500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]